About Envisioneering Medical
Provider of diagnostic and treatment guidance solutions for the healthcare marketplace in the United States. The company develops and commercializes a scanning technology that uses ultrasound imaging to guide diagnostic biopsy sampling and treatment delivery. The products include TargetScan Touch, an ultrasound probe technology platform that serves urologists, radiation oncologists, and physicians in prostate biopsies and treatment. The TargetScan Touch technology collects 3D images using a proprietary robotic probe; leads physicians in mapping prostate locations; and guides biopsy sampling and cancer therapies through needle placement within a defined template
Missing: Envisioneering Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Envisioneering Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Envisioneering Medical Frequently Asked Questions (FAQ)
Where is Envisioneering Medical's headquarters?
Envisioneering Medical's headquarters is located at 1982 Innerbelt Business Center Drive, St. Louis.
What is Envisioneering Medical's latest funding round?
Envisioneering Medical's latest funding round is Series A.
How much did Envisioneering Medical raise?
Envisioneering Medical raised a total of $4M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.